Biocon Corporate Presentation

Research Services (Syngene): A global CRO delivering innovative solutions Offering integrated research, development and manufacturing services for both small and large molecules, antibody-drug conjugates and oligonucleotides backed by best-in-class bioinformatic services Combining world class research expertise, technology and infrastructure to reduce costs and time to market Talented scientific and techno-commercial teams, led by experienced management, moving beyond cost arbitrage to innovation World class infrastructure audited successfully by US FDA, EMA, AAALAC and major life sciences partners 400+ active marquee clients across multiple sectors World-class R&D and manufacturing infrastructure spread over 1.9 million square feet 4700+ talented team of scientists, including ~490 PhDs Strong track record of top-line growth with best-in-class EBITDA margins and Net Profit margin Listed in India on BSE and NSE in 2015 Syngene 22 16

View entire presentation